Drug
Rimonabant clinical trials
Also written SR141716.
- studies test it
- 44
- open now
- 0
- in phase 3
- 35
- first study started
- 2001
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2007 (9)
| Year | Studies |
|---|---|
| 2001 | 4 |
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 5 |
| 2005 | 6 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 6 |
| 2021 | 1 |
| 2022 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 35
- Phase 4
- 1
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 36 · Other 8
Sanofi (35) · Hospital Nacional de Parapléjicos de Toledo (2) · Sinfatin S.L (1) · National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · The Scripps Research Institute (1) · Aristotle University Of Thessaloniki (1) · Weill Medical College of Cornell University (1) · University of Maryland, Baltimore (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Rimonabant is read from its arms, and is right about nine times in ten.
Testing it · 44
- Effect of Rimonabant on Hand Function in Patients With Spinal Cord InjuryActive, not recruitingPhase 1/2Sinfatin S.LNCT07843108Written as Rimonabant
- Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi SyndromeTerminatedPhase 3Weill Medical College of Cornell UniversityNCT00603109Written as rimonabant
- Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryStatus unknownPhase 2Hospital Nacional de Parapléjicos de ToledoNCT05622994Written as Rimonabant
- Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord InjuryCompletedPhase 1/2Hospital Nacional de Parapléjicos de ToledoNCT05398913Written as Rimonabant
- The Effects of Rimonabant, on Weight and Metabolic Risk FactorsTerminatedPhase 2University of Maryland, BaltimoreNCT00547118Written as Rimonabant
- Rimonabant to Reduce Alcohol ConsumptionCompletedPhase 2National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT00075205Written as SR141716 (Rimonabant)
- Clinical and Neurobiological Effects of Cannabis Dependence in Young AdultsCompletedPhase 2The Scripps Research InstituteNCT00656487Written as rimonabant
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseTerminatedPhase 3SanofiNCT00478972Written as Rimonabant
- VIsceral Fat Reduction Assessed by CT-scan On RImonabAntCompletedPhase 3SanofiNCT00299325Written as Rimonabant
- Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugTerminatedPhase 3SanofiNCT00478595Written as Rimonabant
- Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on RimonabantTerminatedPhase 3SanofiNCT00228176Written as Rimonabant
- Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and OutcomesTerminatedPhase 3SanofiNCT00263042Written as Rimonabant
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesTerminatedPhase 3SanofiNCT00577148Written as Rimonabant
- An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesTerminatedPhase 3SanofiNCT00576667Written as Rimonabant
- Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesTerminatedPhase 3SanofiNCT00325650Written as Rimonabant
- Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 DiabetesTerminatedPhase 3SanofiNCT00690456Written as Rimonabant
- Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWithdrawnPhase 3SanofiNCT00754689Written as Rimonabant
- A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 DiabetesTerminatedPhase 3SanofiNCT00449605Written as Rimonabant
- Diagnosis and Therapy of Vulnerable Atherosclerotic PlaqueCompletedNot applicableAristotle University Of ThessalonikiNCT00636766Written as rimonabant
- Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood GlucoseTerminatedPhase 3SanofiNCT00405808Written as Rimonabant
See all 44 studies that test Rimonabant →
Given in every arm · 1 — Rimonabant is usual care beside what is tested
Codes
What other systems call Rimonabant · ClinicalTrials.gg INT006687
- MeSH (NLM) D000077285RimonabantConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) RML78EN3XERIMONABANTConfirmed FDA, NLM, Wikidata
- Wikidata Q412529rimonabantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73244RimonabantOne source FDA
- DrugBank DB06155One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077285 | Rimonabant | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | RML78EN3XE | RIMONABANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q412529 | rimonabant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73244 | Rimonabant | One source FDA |
| DrugBank | DB06155 | — | One source Wikidata |
Also registered as rimonabant hydrochloride (UNII HL0V2LQZ09).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.